Published in Inflammopharmacology on January 01, 1997
Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Exp Immunol (2010) 1.01
Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med (2010) 0.96
Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis. Med Microbiol Immunol (2013) 0.82
Disease-dependent adhesion of lactic acid bacteria to the human intestinal mucosa. Clin Diagn Lab Immunol (2003) 0.82
Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis. Inflammopharmacology (2016) 0.76
The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol Online J (2016) 0.76
The therapeutic effect of probiotics on rheumatoid arthritis: a systematic review and meta-analysis of randomized control trials. Clin Rheumatol (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Probiotics in man and animals. J Appl Bacteriol (1989) 7.43
Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev (1989) 7.03
Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet (1992) 6.66
Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet (1991) 5.46
Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol (1987) 4.53
Intestinal flora in health and disease. Gastroenterology (1984) 3.84
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology (1989) 2.98
Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci (1992) 2.78
A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics (1991) 2.30
Analysis of short-chain acids from bacteria by gas-liquid chromatography with a fused-silica capillary column. J Clin Microbiol (1982) 2.18
Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res (1992) 2.17
The human intestinal microflora. Dig Dis Sci (1986) 2.07
Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet (1988) 1.96
The immune system of human milk: antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J (1993) 1.87
Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect Immun (1991) 1.82
Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis (1986) 1.77
Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell Immunol (1989) 1.68
Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab (1996) 1.53
Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease. Gastroenterology (1981) 1.48
Influence of gastric pH on gastric and jejunal flora. Gut (1967) 1.45
Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis (1987) 1.44
Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology (1993) 1.36
Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol (1985) 1.29
Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci (1994) 1.27
Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins. Eur J Pediatr (1979) 1.23
Food induced ("allergic") arthritis: clinical and serologic studies. J Rheumatol (1990) 1.16
Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet (1986) 1.16
Intestinal flora in early rheumatoid arthritis. Br J Rheumatol (1994) 1.16
Influence of fasting on intestinal permeability and disease activity in patients with rheumatoid arthritis. Scand J Rheumatol (1982) 1.08
Food intolerance in rheumatoid arthritis. I. A double blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Ann Rheum Dis (1992) 1.06
Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol (1988) 1.04
Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheumatol (1987) 1.03
The normal colonic bacterial flora. Gut (1975) 1.01
Non-immunological defence mechanisms of the gut. Gut (1992) 1.00
Intestinal inflammation in children with atopic eczema: faecal eosinophil cationic protein and tumour necrosis factor-alpha as non-invasive indicators of food allergy. Clin Exp Allergy (1996) 0.95
Comparison of faecal florae in patients with rheumatoid arthritis and controls. Br J Rheumatol (1987) 0.95
Gastrointestinal involvement in rheumatoid arthritis: a biopsy study. J Rheumatol (1979) 0.94
Arthritis associated with bowel disease. Clin Gastroenterol (1983) 0.90
Local immune response measured in blood lymphocytes reflects the clinical reactivity of children with cow's milk allergy. Pediatr Res (1990) 0.89
A low molecular weight component derived from the milk of hyperimmunised cows suppresses inflammation by inhibiting neutrophil emigration. Agents Actions (1992) 0.87
Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora? Br J Rheumatol (1996) 0.86
Immune response to prolonged intestinal exposure to antigen. Scand J Immunol (1991) 0.85
Late onset pauciarticular juvenile chronic arthritis: relation to gut inflammation. J Rheumatol (1987) 0.83
Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis. Infect Immun (1984) 0.83
Effects of differing purified cellulose, pectin, and hemicellulose fiber diets on fecal enzymes in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Cancer Res (1986) 0.83
Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model. Med Microbiol Immunol (1992) 0.81
Host defense development in gut and related disorders. Pediatr Clin North Am (1988) 0.79
Administration of milk from cows immunized with intestinal bacteria protects mice from radiation-induced lethality. Biotherapy (1992) 0.78
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00
A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob Agents Chemother (1998) 3.70
Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol (2001) 3.61
Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr (1999) 3.56
Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet (1984) 3.55
FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J (1991) 3.19
Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol (2000) 3.02
Functional food science and gastrointestinal physiology and function. Br J Nutr (1998) 2.78
Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci (1992) 2.78
Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics (1999) 2.45
Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr (1995) 2.30
Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol (1997) 2.26
Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J Clin Microbiol (1998) 2.24
Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet (1983) 2.20
Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res (1992) 2.17
Probiotics: effects on immunity. Am J Clin Nutr (2001) 2.10
Vitamin B-12 status of long-term adherents of a strict uncooked vegan diet ("living food diet") is compromised. J Nutr (1995) 2.08
Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis. Clin Infect Dis (1995) 2.07
Probiotics in the management of atopic eczema. Clin Exp Allergy (2000) 2.00
Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol (2001) 1.93
Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med (1990) 1.90
Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek (1996) 1.86
Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr (1997) 1.80
Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy (2008) 1.79
Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis (1986) 1.77
Grouping of beta-haemolytic streptococci by using coagglutination, precipitation or bacitracin sensitivity. Acta Pathol Microbiol Scand B (1976) 1.77
Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut (2002) 1.74
Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr (1985) 1.73
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J (1997) 1.71
Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal Ed (2000) 1.68
The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol Lett (1998) 1.62
Antioxidant status in vegetarians versus omnivores. Nutrition (2000) 1.58
Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA (1998) 1.57
Influence of mode of delivery on gut microbiota composition in seven year old children. Gut (2004) 1.55
Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med (1990) 1.54
Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab (1996) 1.53
Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy (2000) 1.53
Ability of dairy strains of lactic acid bacteria to bind a common food carcinogen, aflatoxin B1. Food Chem Toxicol (1998) 1.52
Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy (2007) 1.49
Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy (2001) 1.47
Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. Int J Food Microbiol (1995) 1.46
Probiotics: a role in the treatment of intestinal infection and inflammation? Gut (2002) 1.46
Probiotics demonstrating efficacy in clinical settings. Clin Infect Dis (2001) 1.46
Effect of dietary fish powder on intestinal flora and development of arthritis in the pig. Br J Rheumatol (1993) 1.44
An uncooked vegan diet shifts the profile of human fecal microflora: computerized analysis of direct stool sample gas-liquid chromatography profiles of bacterial cellular fatty acids. Appl Environ Microbiol (1992) 1.44
Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis (1998) 1.44
Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax (2008) 1.39
Intrafamilial spread of pertussis. J Pediatr (1983) 1.39
Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child (1995) 1.38
Surface binding of aflatoxin B(1) by lactic acid bacteria. Appl Environ Microbiol (2001) 1.37
Immune response to acute diarrhea seen as circulating antibody-secreting cells. J Infect Dis (1988) 1.37
Quality assurance criteria for probiotic bacteria. Am J Clin Nutr (2001) 1.37
Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis. Clin Exp Immunol (1987) 1.36
Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology (1993) 1.36
Relatedness of Pseudallescheria, Scedosporium and Graphium pro parte based on SSU rDNA sequences. J Med Vet Mycol (1998) 1.33
The unusual γ-ray burst GRB 101225A from a helium star/neutron star merger at redshift 0.33. Nature (2011) 1.31
The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (Lond) (2010) 1.31
Cardiovascular risk factors in the Republic of Karelia, Russia, and in North Karelia, Finland. Int J Epidemiol (1993) 1.30
Effects of mode of delivery and necrotising enterocolitis on the intestinal microflora in preterm infants. Eur J Clin Microbiol Infect Dis (2004) 1.30
Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol (2001) 1.30
A comparative trial of rapid oral and intravenous rehydration in acute diarrhoea. Acta Paediatr Scand (1987) 1.27
Influence of major histocompatibility complex on bacterial composition of fecal flora. Infect Immun (2001) 1.27
Application of gas-liquid chromatographic analysis of cellular fatty acids for species identification and typing of coagulase-negative staphylococci. J Clin Microbiol (1991) 1.27
Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci (1994) 1.27
Double-blind trial of doxicycline in acute maxillary sinusitis. A clinical and bacteriological study. Acta Otolaryngol (1973) 1.25
Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol (2001) 1.24
Milk versus no milk in rapid refeeding after acute gastroenteritis. J Pediatr Gastroenterol Nutr (1986) 1.22
The effect of different antibody affinities on ELISA absorbance and titer. J Immunol Methods (1982) 1.21
Quantitative approach in the study of adhesion of lactic acid bacteria to intestinal cells and their competition with enterobacteria. Appl Environ Microbiol (2000) 1.21
Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia (2011) 1.20
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett Appl Microbiol (2007) 1.20
Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol (2008) 1.19
Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol (2001) 1.19
Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology (1996) 1.19
Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J Dairy Res (2000) 1.18
Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy (1998) 1.18
Phylogenetic analysis of Fusobacterium alocis and Fusobacterium sulci based on 16S rRNA gene sequences: proposal of Filifactor alocis (Cato, Moore and Moore) comb. nov. and Eubacterium sulci (Cato, Moore and Moore) comb. nov. Int J Syst Bacteriol (1999) 1.18
Rapid identification of group A, B, C and G beta-haemolytic Streptococci by a modification of the co-agglutination technique. Comparison of results obtained by co-agglutination, fluorescent antibody test, counterimmunoelectrophoresis, and precipitin technique. Acta Pathol Microbiol Scand B (1978) 1.18